Police & Firemen s Retirement System of New Jersey Raises Stock Holdings in Chemed Corporation $CHE

Police & Firemen s Retirement System of New Jersey boosted its stake in shares of Chemed Corporation (NYSE:CHE) by 2.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,459 shares of the company’s stock after purchasing an additional 156 shares during the quarter. Police & Firemen s Retirement System of New Jersey’s holdings in Chemed were worth $2,658,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the company. Creekmur Asset Management LLC bought a new stake in shares of Chemed in the 2nd quarter valued at about $28,000. SVB Wealth LLC purchased a new stake in Chemed during the first quarter valued at approximately $30,000. WPG Advisers LLC acquired a new stake in Chemed in the first quarter valued at approximately $32,000. Parkside Financial Bank & Trust grew its holdings in Chemed by 86.3% in the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock worth $46,000 after purchasing an additional 44 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its position in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on CHE. Oppenheimer lowered their price objective on Chemed from $650.00 to $580.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Bank of America decreased their price target on Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and boosted their price target for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Royal Bank Of Canada cut their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Chemed currently has a consensus rating of “Moderate Buy” and a consensus price target of $574.25.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 3,000 shares of the stock in a transaction dated Friday, September 26th. The stock was sold at an average price of $461.28, for a total transaction of $1,383,840.00. Following the sale, the chief executive officer directly owned 96,197 shares of the company’s stock, valued at approximately $44,373,752.16. This trade represents a 3.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Patrick P. Grace sold 150 shares of Chemed stock in a transaction dated Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the transaction, the director owned 3,397 shares of the company’s stock, valued at $1,574,135.83. The trade was a 4.23% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 3.29% of the company’s stock.

Chemed Stock Performance

Shares of CHE stock opened at $435.49 on Wednesday. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The firm has a market capitalization of $6.17 billion, a PE ratio of 23.03, a P/E/G ratio of 2.69 and a beta of 0.43. The stock’s 50-day simple moving average is $442.78 and its 200-day simple moving average is $480.87.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing analysts’ consensus estimates of $5.39 by ($0.12). Chemed had a net margin of 11.02% and a return on equity of 25.89%. The firm had revenue of $624.90 million during the quarter, compared to analysts’ expectations of $626.04 million. During the same quarter in the prior year, the company earned $5.64 EPS. Chemed’s quarterly revenue was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Sell-side analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Monday, November 17th will be paid a $0.60 dividend. The ex-dividend date is Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio is presently 12.69%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.